Drug Type Synthetic peptide |
Synonyms |
Target |
Mechanism FGF21 modulators(Fibroblast growth factor 21 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Nonalcoholic Steatohepatitis | Preclinical | CN | 01 Nov 2024 |